Comparison of Medical Marijuana Articles

Musty and Rossi reconsidered facts and numbers from a sequence of state-sponsored clinical tests of marijuana for respite of nausea and vomiting initiated by cancerous infection chemotherapy undertook in the 1970s and 1980s, completing, “Patients who smoked marijuana skilled 70-100% respite from nausea and vomiting, while those who utilized the THC capsule skilled 76-88% relief.” (Musty & Rossi, 43-56)

They furthermore analyzed the facts and numbers considering use of marijuana and cannabinoids in cancerous infection treatment. He resolved that marijuana/cannabinoids can be helpful in stopping or healing “chemotherapy-induced nausea and vomiting.” He furthermore documented that cannabinoids have promise as antitumor agents: “Regarding effectiveness, cannabinoids use a prominent antitumour activity… Regarding toxicity, cannabinoids not only display a good security profile but furthermore have palliative consequences in patients with cancerous infection, showing that clinical tests with cannabinoids in cancerous infection treatment are feasible.”

Sylvestre et al undertook a potential observational study on 71 patients to characterize the influence of cannabis use throughout interferon/ribavirin remedy for the hepatitis C virus (Sylvestre et al, 1057-63). Compared to non-users, marijuana users had three times the rate of maintained virological answer, evidently due to better remedy adherence. The investigators asserted, “The use of cannabis throughout HCV remedy can advance adherence by expanding the length of time that patients stay on therapy; this converts to decrease rates of post-treatment virological relapse.”

Many patients need the use of adjunctive pharmacological agencies for side-effect management. These encompass a spectrum of medications encompassing antiemetics, anti-inflammatory agencies, antihistamines, dozing tablets, antidepressants, anxiolytics, stimulants, and antipsychotics. Unfortunately, symptom respite is often incomplete regardless of the prevalent use of polypharmacy, and patients so influenced may reimburse by decreasing their interferon or ribavirin doses or by ceasing remedy altogether.

The outcomes of this observational study propose that the use of cannabis throughout HCV remedy ...